Publication: Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?
dc.contributor.author | Quiles, José L | |
dc.contributor.author | Rivas-García, Lorenzo | |
dc.contributor.author | Varela-López, Alfonso | |
dc.contributor.author | Llopis, Juan | |
dc.contributor.author | Battino, Maurizio | |
dc.contributor.author | Sánchez-González, Cristina | |
dc.date.accessioned | 2023-02-09T09:39:04Z | |
dc.date.available | 2023-02-09T09:39:04Z | |
dc.date.issued | 2020-08-22 | |
dc.description.abstract | The repositioning of therapeutic agents already approved by the regulatory agencies for the use of drugs is very interesting due to the immediacy of their use; similarly, the possibility of using molecules derived from foods, whether nutrients or not, is of great importance, also because of their immediate therapeutic applicability. Candidates for these natural therapies against COVID-19 should show certain effects, such as restoring mitochondrial function and cellular redox balance. This would allow reducing the susceptibility of risk groups and the cascade of events after SARS-CoV-2 infection, responsible for the clinical picture, triggered by the imbalance towards oxidation, inflammation, and cytokine storm. Possible strategies to follow through the use of substances of food origin would include: a) the promotion of mitophagy to remove dysfunctional mitochondria originating from free radicals, proton imbalance and virus evasion of the immune system; b) the administration of transition metals whose redox activity would lead to their own oxidation and the consequent generation of a reduced environment, which would normalize the oxidative state and the intracellular pH; c) the administration of molecules with demonstrated antioxidant capacity; d) the administration of compounds with anti-inflammatory and vasodilatory activity; e) the administration of immunomodulatory compounds. | |
dc.identifier.doi | 10.1016/j.envres.2020.110053 | |
dc.identifier.essn | 1096-0953 | |
dc.identifier.pmc | PMC7442575 | |
dc.identifier.pmid | 32835682 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442575/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.envres.2020.110053 | |
dc.identifier.uri | http://hdl.handle.net/10668/16142 | |
dc.journal.title | Environmental research | |
dc.journal.titleabbreviation | Environ Res | |
dc.language.iso | en | |
dc.organization | IBS | |
dc.page.number | 110053 | |
dc.pubmedtype | Journal Article | |
dc.rights.accessRights | open access | |
dc.subject | Curcumin | |
dc.subject | Polyphenols | |
dc.subject | Vitamin C | |
dc.subject | Vitamin D | |
dc.subject | Zinc | |
dc.subject.mesh | Antioxidants | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Functional Food | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Mitochondria | |
dc.subject.mesh | Nutrients | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | SARS-CoV-2 | |
dc.title | Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19? | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 191 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1